Maggiolo F, Rizzardini G, Molina JM, Pulido F, et al. Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people >/=65 years of age. HIV Med 2022 May 8. doi: 10.1111/hiv.13319.
PMID: 35527425